Skip to main content
. Author manuscript; available in PMC: 2015 May 8.
Published in final edited form as: Antivir Ther. 2014 Aug 8;20(2):199–208. doi: 10.3851/IMP2821

Figure 2. Percentage of individuals with resistance mutations present in the (A) NS3 protease gene (n=49), NS5B polymerase gene (n=49) and (C) NS5A gene (n=13).

Figure 2

Resistance mutations are represented as occuring at >50% (“Dominant”, solid bars), >1–50% (grey hatched bars), >0.1–1% (light grey hatched bars). All mutations known to confer resistance at each position were catergorised together, irrespective of the amino acid change. For particpants who had evidence of multiple mutations at one site (eg. Both M423T andM423V), the mutation seen at higher % was reported. No mutations were found to occur in the range between 3 and 88%. Dominant resistant mutations generally occurred at > 98%.